Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye
- Status
- UNKNOWN
- Phase
- NA
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- NA
S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2